Viewing Study NCT06403761


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2025-12-28 @ 7:50 AM
Study NCT ID: NCT06403761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-28
First Post: 2024-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module